277 related articles for article (PubMed ID: 24394188)
1. Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.
Patel P; Kriz J; Gravel M; Soucy G; Bareil C; Gravel C; Julien JP
Mol Ther; 2014 Mar; 22(3):498-510. PubMed ID: 24394188
[TBL] [Abstract][Full Text] [Related]
2. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Leyton-Jaimes MF; Kahn J; Israelson A
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.
Foust KD; Salazar DL; Likhite S; Ferraiuolo L; Ditsworth D; Ilieva H; Meyer K; Schmelzer L; Braun L; Cleveland DW; Kaspar BK
Mol Ther; 2013 Dec; 21(12):2148-59. PubMed ID: 24008656
[TBL] [Abstract][Full Text] [Related]
4. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.
Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J
J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481
[TBL] [Abstract][Full Text] [Related]
5. Single chain variable fragment antibodies directed against SOD1 ameliorate disease in mutant SOD1 transgenic mice.
Ghadge GD; Kay BK; Drigotas C; Roos RP
Neurobiol Dis; 2019 Jan; 121():131-137. PubMed ID: 30176351
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
Stoica L; Todeasa SH; Cabrera GT; Salameh JS; ElMallah MK; Mueller C; Brown RH; Sena-Esteves M
Ann Neurol; 2016 Apr; 79(4):687-700. PubMed ID: 26891182
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.
Gros-Louis F; Soucy G; Larivière R; Julien JP
J Neurochem; 2010 Jun; 113(5):1188-99. PubMed ID: 20345765
[TBL] [Abstract][Full Text] [Related]
8. ALS-linked misfolded SOD1 species have divergent impacts on mitochondria.
Pickles S; Semmler S; Broom HR; Destroismaisons L; Legroux L; Arbour N; Meiering E; Cashman NR; Vande Velde C
Acta Neuropathol Commun; 2016 Apr; 4(1):43. PubMed ID: 27121871
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.
Sábado J; Casanovas A; Rodrigo H; Arqué G; Esquerda JE
Neuroscience; 2015 Dec; 310():38-50. PubMed ID: 26384962
[TBL] [Abstract][Full Text] [Related]
10. An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS.
Dong QX; Zhu J; Liu SY; Yu XL; Liu RT
Int Immunopharmacol; 2018 Dec; 65():413-421. PubMed ID: 30388515
[TBL] [Abstract][Full Text] [Related]
11. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
Wang H; Yang B; Qiu L; Yang C; Kramer J; Su Q; Guo Y; Brown RH; Gao G; Xu Z
Hum Mol Genet; 2014 Feb; 23(3):668-81. PubMed ID: 24108104
[TBL] [Abstract][Full Text] [Related]
12. Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.
Zetterström P; Graffmo KS; Andersen PM; Brännström T; Marklund SL
J Biol Chem; 2011 Jun; 286(23):20130-6. PubMed ID: 21493711
[TBL] [Abstract][Full Text] [Related]
13. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis.
Maier M; Welt T; Wirth F; Montrasio F; Preisig D; McAfoose J; Vieira FG; Kulic L; Späni C; Stehle T; Perrin S; Weber M; Hock C; Nitsch RM; Grimm J
Sci Transl Med; 2018 Dec; 10(470):. PubMed ID: 30518612
[TBL] [Abstract][Full Text] [Related]
14. Identification of a misfolded region in superoxide dismutase 1 that is exposed in amyotrophic lateral sclerosis.
Rotunno MS; Auclair JR; Maniatis S; Shaffer SA; Agar J; Bosco DA
J Biol Chem; 2014 Oct; 289(41):28527-38. PubMed ID: 25164820
[TBL] [Abstract][Full Text] [Related]
15. Treatment of a Mouse Model of ALS by In Vivo Base Editing.
Lim CKW; Gapinske M; Brooks AK; Woods WS; Powell JE; Zeballos C MA; Winter J; Perez-Pinera P; Gaj T
Mol Ther; 2020 Apr; 28(4):1177-1189. PubMed ID: 31991108
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1.
Pickles S; Destroismaisons L; Peyrard SL; Cadot S; Rouleau GA; Brown RH; Julien JP; Arbour N; Vande Velde C
Hum Mol Genet; 2013 Oct; 22(19):3947-59. PubMed ID: 23736301
[TBL] [Abstract][Full Text] [Related]
17. Blocking an epitope of misfolded SOD1 ameliorates disease phenotype in a model of amyotrophic lateral sclerosis.
Bakavayev S; Stavsky A; Argueti-Ostrovsky S; Yehezkel G; Fridmann-Sirkis Y; Barak Z; Gitler D; Israelson A; Engel S
Brain; 2023 Nov; 146(11):4594-4607. PubMed ID: 37394908
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAi.
Towne C; Aebischer P
Methods Mol Biol; 2009; 555():87-108. PubMed ID: 19495690
[TBL] [Abstract][Full Text] [Related]
19. Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice.
Takeuchi S; Fujiwara N; Ido A; Oono M; Takeuchi Y; Tateno M; Suzuki K; Takahashi R; Tooyama I; Taniguchi N; Julien JP; Urushitani M
J Neuropathol Exp Neurol; 2010 Oct; 69(10):1044-56. PubMed ID: 20838241
[TBL] [Abstract][Full Text] [Related]
20. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
Ayers JI; Fromholt S; Sinyavskaya O; Siemienski Z; Rosario AM; Li A; Crosby KW; Cruz PE; DiNunno NM; Janus C; Ceballos-Diaz C; Borchelt DR; Golde TE; Chakrabarty P; Levites Y
Mol Ther; 2015 Jan; 23(1):53-62. PubMed ID: 25228069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
